Market Tracker

10/31 7:05pm ET

Haemonetics Corp (NYSE:HAE)

37.72
Data as of Oct 31
 -0.72 / -1.87%
Today’s Change
29.86
Today|||52-Week Range
44.20
-10.47%
Year-to-Date

Today’s Trading

Previous close38.44
Today’s open39.04
Day’s range37.65 - 39.07
Volume377,357
Average volume (3 months)240,191
Market cap$2.0B
Dividend yield--
Data as of 4:03pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-9.46%
Earnings growth (this year)-13.33%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+5.22%
P/E ratio50.3
Price/Sales1.77
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
GMEDGlobus Medical Inc+1.27+6.08%
EXASExact Sciences Corp-0.74-2.98%
NUVANuVasive Inc+1.64+4.18%
IARTIntegra LifeSciences...+1.37+2.75%
Data as of 4:03pm ET, 10/31/2014

Financials

Next reporting dateNovember 3, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$938.5M
Annual profit (last year)$35.1M
Net profit margin3.75%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Financial Officer &
EVP-Business Development
Christopher J. Lindop
Corporate headquarters
Braintree, Massachusetts

Forecasts